| 1928 |
Vimtrup [77] |
acid maceration |
not reported |
5 |
children (3), adults (2) |
887,399 |
833,992–1,233,360 |
| 1931 |
Moore [78] |
acid maceration |
mostly infectious |
29 |
1–74 |
794,253 |
427,697–1,040,671 |
| 1933 |
Hayman and Johnson [79] |
acid maceration |
no kidney pathology |
11 |
19–75 |
1,230,000 |
800,000–1,530,000 |
|
|
|
kidney pathology |
23 |
23–51 |
393,000 |
156,000–1,330,000 |
| 1934 |
Moritz and Hayman [80] |
acid maceration |
no kidney pathology (mercuric chloride (n=3) |
14 |
1 hr–88 |
1,287,500 |
940,000–1,542,000 |
|
|
|
kidney pathology |
21 |
21–85 |
595,000 |
155,000–1,154,000 |
| 1973 |
Dunnill and Halley [81] |
acid maceration |
|
18 |
1 day–61 |
908,333 |
600,000–1,150,000 |
| 1977 |
McLachlan et al [82] |
acid maceration |
|
32 |
20–91 |
1,309,280 (359,960) |
580,000–2,000,000 |
|
|
|
|
19 |
male: 20–91 (mean: 60) |
1,363,870 (371,840) |
|
|
|
|
1 |
13 |
female: 43–89 (mean: 70) |
1,229,450 (340,160) |
|
| 1993 |
Merlet-Benichou et al [7] |
acid maceration |
|
28 |
|
1,107,000 |
655,000–1,554,000 |
|
|
|
|
|
|
|
|
| 1992 |
Nyengaard and Bendtsen [3] |
fractionator-disector |
no gross kidney pathology |
37 |
16–87 |
608,000 |
331,000–1,424,000 |
|
|
|
excluded: HTN, abnormal kidney function |
|
|
|
|
| 1993 |
Hinchliffe et al [11] |
dissector-cavalieri |
|
16 |
fetuses |
903,000 |
740,000–1,060,000 |
| 2003 |
Keller et al [4] |
fractionator-disector |
no HTN |
10 |
34–54 |
1,429,200 |
531,140–954,893 |
|
|
|
HTN |
10 |
35–59 |
724,307 |
884,458–1,959,914 |
| 2011 |
Bertram et al [5] |
fractionator-disector |
|
398 |
|
895,711 |
210,332–2,702,079 |
|
|
|
African Americans |
176 |
|
898,748 |
210,332–2,702,079 |
|
|
|
white Americans |
132 |
|
894,119 |
227,327–1,660,232 |
|
|
|
Aboriginal Australian |
19 |
|
713,209 |
364,161–1,129,233 |
|
|
> |
White Australians |
24 |
|
861,541 |
380,517–1,493,665 |
|
|
|
Senegalese |
47 |
|
988,263 |
536,171–176,4421 |
| 2008 |
Zhang et al [83] |
fractionator-disector |
|
15 |
<3 months |
NA |
246,181–1,106,062 |
|
|
|
|
|
|
|
|
| 2014 |
Beeman et al [66] |
CFE-MRI |
hypertensive (n=1) |
3 |
37–68 |
1,110,000 |
740,000–1,460,000 |
| 2003 |
Fulladosa et al [62] |
MRI and protocol biopsy |
stable renal transplant patients |
39 |
38 (range: 14–76) |
730,000 (330,000) |
|
| 2010 |
Tan et al [84] |
whole kidney Kf |
kidney donors |
15 |
<45 years |
821000 |
|
|
|
|
|
19 |
>55 years |
576000 |
|
| 2015 |
Lenihan et al [85] |
whole kidney Kf |
healthy kidney donors |
19 |
54.8 ± 6.5 |
641,730 |
396,554–713,399 |
| 2015 |
Lenihan et al [86] |
whole kidney Kf |
young normotensive |
24 |
33.5 (29–42) |
797,250 (443,668) |
|
|
|
|
normotensive kidney donors |
17 |
56 (55–59.6) |
561,774 (225,774) |
|
|
|
|
hypertensive kidney donors |
10 |
58 (55.75–61.5) |
457,752 (176,140) |
|
| 2017 |
Denic at al [40] |
CT angiogram and implantation biopsy |
healthy kidney donors |
246 |
18–29 |
990,661 |
|
|
|
|
|
11 |
70–75 |
520,410 |
|
|
|
|
|
1638 |
43 +/− 11.7 |
873,696 |
|